MedTrace Logo

Clinical Trial of Oral Midazolam in Pediatric Endoscopy

NCT00636428 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2008-04-11

No results posted yet for this study

Summary

The objective of our study was to compare the safety and efficacy of oral midazolam during pediatric endoscopy.

Conditions

  • Endoscopy

Interventions

DRUG

Midazolam

oral midazolam, was prepared into a final solution (2.5 mg/mL) from injectable midazolam hydrochloride and a orange flavored syrup. For preparation, midazolam injection (5 mg/mL) was diluted 1:1 with the flavored syrup.

Sponsors & Collaborators

  • Tabriz University

    lead OTHER

Principal Investigators

  • mandana Rafeey, Dr · liver &Gastrointestinal Research center of tabriz medical university

  • Mandana Rafeey, Dr · tabriz medical university

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00636428 on ClinicalTrials.gov